These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 11700425)

  • 21. Should beta-blockers be used for the treatment of pediatric patients with chronic heart failure?
    Bruns LA; Canter CE
    Paediatr Drugs; 2002; 4(12):771-8. PubMed ID: 12431129
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased endogenous nitric oxide synthase inhibitor in patients with congestive heart failure.
    Usui M; Matsuoka H; Miyazaki H; Ueda S; Okuda S; Imaizumi T
    Life Sci; 1998; 62(26):2425-30. PubMed ID: 9651109
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inter-relationship between tumour necrosis factor-alpha (TNF-alpha) and TNF soluble receptors in pulmonary sarcoidosis.
    Armstrong L; Foley NM; Millar AB
    Thorax; 1999 Jun; 54(6):524-30. PubMed ID: 10335007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alterations in immunocyte tumor necrosis factor receptor and apoptosis in patients with congestive heart failure.
    Rumalla VK; Calvano SE; Spotnitz AJ; Krause TJ; Hilkert RJ; Lin E; Lowry SF
    Ann Surg; 2002 Aug; 236(2):254-60. PubMed ID: 12170032
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional improvement in heart failure patients treated with beta-blockers is associated with a decline of cytokine levels.
    Mayer B; Holmer SR; Hengstenberg C; Lieb W; Pfeifer M; Schunkert H
    Int J Cardiol; 2005 Aug; 103(2):182-6. PubMed ID: 16080978
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathophysiological correlates of increased serum tumor necrosis factor in patients with congestive heart failure. Relation to nitric oxide-dependent vasodilation in the forearm circulation.
    Katz SD; Rao R; Berman JW; Schwarz M; Demopoulos L; Bijou R; LeJemtel TH
    Circulation; 1994 Jul; 90(1):12-6. PubMed ID: 8025986
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice.
    Liao Y; Asakura M; Takashima S; Ogai A; Asano Y; Shintani Y; Minamino T; Asanuma H; Sanada S; Kim J; Kitamura S; Tomoike H; Hori M; Kitakaze M
    Circulation; 2004 Aug; 110(6):692-9. PubMed ID: 15262839
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of inhaled nitric oxide on raised pulmonary vascular resistance in children with congenital heart disease.
    Winberg P; Lundell BP; Gustafsson LE
    Br Heart J; 1994 Mar; 71(3):282-6. PubMed ID: 8142199
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytokine priming reduces dependence on TNF-R2 for TNF-alpha-mediated induction of macrophage nitric oxide generation.
    Miller AR; Suttles J; Stout RD
    J Interferon Cytokine Res; 1996 Dec; 16(12):1055-63. PubMed ID: 8974009
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor necrosis factor in congestive heart failure: a mechanism of disease for the new millennium?
    Ceconi C; Curello S; Bachetti T; Corti A; Ferrari R
    Prog Cardiovasc Dis; 1998; 41(1 Suppl 1):25-30. PubMed ID: 9715820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Propranolol induces regression of hemangioma cells via the down-regulation of the PI3K/Akt/eNOS/VEGF pathway.
    Pan WK; Li P; Guo ZT; Huang Q; Gao Y
    Pediatr Blood Cancer; 2015 Aug; 62(8):1414-20. PubMed ID: 25728347
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor necrosis factor receptors 1 and 2 differentially regulate survival, cardiac dysfunction, and remodeling in transgenic mice with tumor necrosis factor-alpha-induced cardiomyopathy.
    Higuchi Y; McTiernan CF; Frye CB; McGowan BS; Chan TO; Feldman AM
    Circulation; 2004 Apr; 109(15):1892-7. PubMed ID: 15051641
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heart rate variability in infants with heart failure due to congenital heart disease: reversal of depressed heart rate variability by propranolol.
    Buchhorn R; Hulpke-Wette M; Nothroff J; Paul T
    Med Sci Monit; 2002 Oct; 8(10):CR661-6. PubMed ID: 12388917
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of tumour necrosis factor-alpha receptor p75 in cigarette smoke-induced pulmonary inflammation and emphysema.
    D'hulst AI; Bracke KR; Maes T; De Bleecker JL; Pauwels RA; Joos GF; Brusselle GG
    Eur Respir J; 2006 Jul; 28(1):102-12. PubMed ID: 16540505
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of ghrelin and insulin-like growth factor-1 in immature piglet model of chronic cyanotic congenital heart defects with decreased pulmonary blood flow.
    Wang D; Liu YL; Lü XD; Zhu YB; Ling F; Liu AJ; Li G; Xu YL
    Chin Med J (Engl); 2011 Aug; 124(15):2354-60. PubMed ID: 21933568
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beta blocker and angiotensin-converting enzyme inhibitor therapy is associated with decreased Th1/Th2 cytokine ratios and inflammatory cytokine production in patients with chronic heart failure.
    Gage JR; Fonarow G; Hamilton M; Widawski M; Martínez-Maza O; Vredevoe DL
    Neuroimmunomodulation; 2004; 11(3):173-80. PubMed ID: 15067208
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduction in lymphocyte beta-adrenergic receptor density in infants and children with heart failure secondary to congenital heart disease.
    Wu JR; Chang HR; Huang TY; Chiang CH; Chen SS
    Am J Cardiol; 1996 Jan; 77(2):170-4. PubMed ID: 8546086
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute effects of beta 1-selective and nonselective beta-adrenergic receptor blockade on cardiac sympathetic activity in congestive heart failure.
    Newton GE; Parker JD
    Circulation; 1996 Aug; 94(3):353-8. PubMed ID: 8759076
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Role of the TNF system in the pathomechanism of bronchial asthma].
    Halász A; Cserháti E; Cseh K
    Orv Hetil; 2002 Mar; 143(11):553-7. PubMed ID: 12583324
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protection against lung damage in reduced-size liver transplantation.
    Franco-Gou R; Roselló-Catafau J; Peralta C
    Crit Care Med; 2006 May; 34(5):1506-13. PubMed ID: 16540955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.